NCT04534023View on ClinicalTrials.gov

A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies

PHASE2RecruitingINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

September 1, 2026

Study Completion Date

September 30, 2026

Conditions
Rapid Eye Movement Sleep Behavior DisorderSynucleinopathy
Interventions
DRUG

Idebenone

trial group

DRUG

Placebo

control group

Trial Locations (1)

200025

RECRUITING

Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
collaborator

Second Affiliated Hospital of Soochow University

OTHER

collaborator

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER

lead

Ruijin Hospital

OTHER